Chemomab Therapeutics (CMMB) Non-cash Items (2020 - 2023)
Chemomab Therapeutics (CMMB) posted Non-cash Items of -$1.1 million for Q3 2023, down 335.74% on a QoQ basis from $484000.0 in Q2 2023, and down 140.39% year-over-year from $2.8 million in Q3 2022.
Chemomab Therapeutics (CMMB) Non-cash Items (2020 - 2023) Analysis & Trends
Chemomab Therapeutics' Non-cash Items history runs 4 years deep, the most recent figure standing at -$1.1 million for Q3 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Chemomab Therapeutics | 124.14 Mn | 113.77 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2023 | -1.14 Mn |
| Sep 30, 2023 | -1.14 Mn |
| Jun 30, 2023 | 484,000.00 |
| Jun 30, 2023 | 484,000.00 |
| Mar 31, 2023 | 1.57 Mn |
| Mar 31, 2023 | 1.57 Mn |
| Sep 30, 2022 | 2.83 Mn |
| Sep 30, 2022 | 2.83 Mn |
| Jun 30, 2022 | 489,000.00 |
| Jun 30, 2022 | 489,000.00 |
| Mar 31, 2022 | 1.39 Mn |
| Mar 31, 2022 | 1.39 Mn |
| Sep 30, 2021 | 388,000.00 |
| Sep 30, 2021 | 388,000.00 |
| Jun 30, 2021 | -2.84 Mn |
| Jun 30, 2021 | -2.84 Mn |
| Mar 31, 2021 | 411,000.00 |
| Mar 31, 2021 | 411,000.00 |
| Sep 30, 2020 | 323,000.00 |
| Sep 30, 2020 | 323,000.00 |